TCMIP v2.0 Powers the Identification of Chemical Constituents Available in Xinglou Chengqi Decoction and the Exploration of Pharmacological Mechanisms Acting on Stroke Complicated With Tanre Fushi Syndrome

Xinglou Chengqi (XLCQ) decoction, composed of three botanical drugs and one inorganic drug, is used in clinics during the treatment of acute stroke complicated with Tanre Fushi (TRFS) syndrome in China. However, its active ingredients and the molecular mechanism have not been clarified. So, we aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ping, Wang, Shuang, Chen, Hong, Deng, Xiaofang, Zhang, Luoqi, Xu, Haiyu, Yang, Hongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320350/
https://www.ncbi.nlm.nih.gov/pubmed/34335236
http://dx.doi.org/10.3389/fphar.2021.598200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320350/
https://www.ncbi.nlm.nih.gov/pubmed/34335236
http://dx.doi.org/10.3389/fphar.2021.598200

Ejemplares similares